Work

Evolving Landscape of Initial Treatments for Patients with Malignant Pleural Mesotheliomas: Clinical Trials to Clinical Practice

Year: 2022

Type: article

Abstract: Malignant pleural mesothelioma (MPM) is the most common form of mesothelioma and the type most often studied in prospective clinical trials.This review reports the trials that have shaped first-line treatment for patients with advanced/unresectable MPM and the real-world integration of first-line immune checkpoint inhibitors into clinical practice.

Source: The Oncologist

DOI: 10.1093/oncolo/oyac113

Authors: Michael Offin, Valerie W Rusch, Andreas Rimner, Prasad S Adusumilli, Marjorie G Zauderer

Institution: Memorial Sloan Kettering Cancer Center

Language: English

Topic: Occupational and environmental lung diseases

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $3,494